GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (STU:7JN) » Definitions » Notes Receivable

Poolbeg Pharma (STU:7JN) Notes Receivable : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma Notes Receivable?

Poolbeg Pharma's Notes Receivable for the quarter that ended in Jun. 2024 was €0.00 Mil.


Poolbeg Pharma Notes Receivable Historical Data

The historical data trend for Poolbeg Pharma's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Notes Receivable Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23
Notes Receivable
- - -

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Notes Receivable Get a 7-Day Free Trial - - - - -

Poolbeg Pharma Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Poolbeg Pharma Notes Receivable Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Poolbeg Pharma Business Description

Traded in Other Exchanges
Address
42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines